Key facts
- BIOHM Health’s last known valuation is $37.0M (Feb 2025).
- It has raised $13.0M across 4 recorded rounds; the latest was Seed Round ($1.5M) in Feb 2025.
- Notable investors include Jumpstart Ventures, JobsOhio Ventures, Vanterra Ventures, University Hospitals Ventures, Felton Group — 15 tracked in total.
- BIOHM Health has filed 4 Form Ds with the SEC since 2023, most recently Feb 2025 ($1.5M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for BIOHM Health
Funding rounds
4 roundsAbout BIOHM Health
Manufacturer of gut health products and kits intended to help people understand their gut microbiome. The company's products and kits optimize digestive health by combining good bacteria, good fungi, and enzymes to break down digestive plaque, enabling consumers to make informed decisions about their health with insights into their gut health and personalized diet, lifestyle, and supplements recommendations.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Cleveland, OH, United States
- Founded
- 2016
- Employees
- 24
- Website
- biohmhealth.com/
- Ownership
- Privately Held (backing)
BIOHM Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BIOHM Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BIOHM Health in its N-PORT filings yet. We sweep new filings monthly.